1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
Hestad, K.A.; Engedal, K.; Whist, J.E.; Aukrust, P.; Farup, P.G.; Mollnes, T.E.; Ueland, T. Patients with depression display cytokine
levels in serum and cerebrospinal fluid similar to patients with diffuse neurological symptoms without a defined diagnosis.
Neuropsychiatr. Dis. Treat 2016, 12, 817–822. [CrossRef] [PubMed]
Felger, J.C.; Lotrich, F.E. Inflammatory cytokines in depression: Neurobiological mechanisms and therapeutic implications.
Neuroscience 2013, 246, 199–229. [CrossRef]
Tanaka, K.; Furuyashiki, T.; Kitaoka, S.; Senzai, Y.; Imoto, Y.; Segi-Nishida, E.; Deguchi, Y.; Breyer, R.M.; Breyer, M.D.; Narumiya,
S. Prostaglandin E2-mediated attenuation of mesocortical dopaminergic pathway is critical for susceptibility to repeated social
defeat stress in mice. J. Neurosci. 2012, 32, 4319–4329. [CrossRef]
Koo, J.W.; Duman, R.S. IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc. Natl. Acad.
Sci. USA 2008, 105, 751–756. [CrossRef] [PubMed]
Ohgidani, M.; Kato, T.A.; Sagata, N.; Hayakawa, K.; Shimokawa, N.; Sato-Kasai, M.; Kanba, S. TNF-α from hippocampal microglia
induces working memory deficits by acute stress in mice. Brain Behav. Immun. 2016, 55, 17–24. [CrossRef] [PubMed]
Lotze, M.T.; Tracey, K.J. High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal. Nat. Rev. Immunol.
2005, 5, 331–342. [CrossRef]
Wang, H.; Bloom, O.; Zhang, M.; Vishnubhakat, J.M.; Ombrellino, M.; Che, J.; Frazier, A.; Yang, H.; Ivanova, S.; Borovikova, L.;
et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285, 248–251. [CrossRef]
Liu, K.; Mori, S.; Takahashi, H.K.; Tomono, Y.; Wake, H.; Kanke, T.; Sato, Y.; Hiraga, N.; Adachi, N.; Yoshino, T.; et al. Anti-high
mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats. FASEB J. 2007, 21,
3904–3916. [CrossRef]
Sasaki, T.; Liu, K.; Agari, T.; Yasuhara, T.; Morimoto, J.; Okazaki, M.; Takeuchi, H.; Toyoshima, A.; Sasada, S.; Shinko, A.; et al.
Anti-high mobility group box 1 antibody exerts neuroprotection in a rat model of Parkinson’s disease. Exp. Neurol. 2016, 275 Pt 1,
220–231. [CrossRef]
Gao, H.M.; Zhou, H.; Zhang, F.; Wilson, B.C.; Kam, W.; Hong, J.S. HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration. J. Neurosci. 2011, 31, 1081–1092. [CrossRef]
Fu, L.; Liu, K.; Wake, H.; Teshigawara, K.; Yoshino, T.; Takahashi, H.; Mori, S.; Nishibori, M. Therapeutic effects of anti-HMGB1
monoclonal antibody on pilocarpine-induced status epilepticus in mice. Sci. Rep. 2017, 7, 1179. [CrossRef] [PubMed]
Zhao, J.; Wang, Y.; Xu, C.; Liu, K.; Chen, L.; Wu, X.; Gao, F.; Guo, Y.; Zhu, J.; Wang, S.; et al. Therapeutic potential of an anti-high
mobility group box-1 monoclonal antibody in epilepsy. Brain Behav. Immun. 2017, 64, 308–319. [CrossRef]
Maroso, M.; Balosso, S.; Ravizza, T.; Liu, J.; Aronica, E.; Iyer, A.M.; Rossetti, C.; Molteni, M.; Casalgrandi, M.; Manfredi, A.A.; et al.
Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat. Med.
2010, 16, 413–419. [CrossRef] [PubMed]
Lian, Y.J.; Gong, H.; Wu, T.Y.; Su, W.J.; Zhang, Y.; Yang, Y.Y.; Peng, W.; Zhang, T.; Zhou, J.R.; Jiang, C.L.; et al. Ds-HMGB1 and
fr-HMGB induce depressive behavior through neuroinflammation in contrast to nonoxid-HMGB1. Brain Behav. Immun. 2017, 59,
322–332. [CrossRef] [PubMed]
Franklin, T.C.; Wohleb, E.S.; Zhang, Y.; Fogaça, M.; Hare, B.; Duman, R.S. Persistent Increase in Microglial RAGE Contributes to
Chronic Stress-Induced Priming of Depressive-like Behavior. Biol. Psychiatry 2018, 83, 50–60. [CrossRef] [PubMed]
Yanai, H.; Matsuda, A.; An, J.; Koshiba, R.; Nishio, J.; Negishi, H.; Ikushima, H.; Onoe, T.; Ohdan, H.; Yoshida, N.; et al.
Conditional ablation of HMGB1 in mice reveals its protective function against endotoxemia and bacterial infection. Proc. Natl.
Acad. Sci. USA 2013, 110, 20699–20704. [CrossRef] [PubMed]
Sakatani, S.; Yamada, K.; Homma, C.; Munesue, S.; Yamamoto, Y.; Yamamoto, H.; Hirase, H. Deletion of RAGE causes
hyperactivity and increased sensitivity to auditory stimuli in mice. PLoS ONE 2009, 4, e8309. [CrossRef]
Nie, X.; Kitaoka, S.; Tanaka, K.; Segi-Nishida, E.; Imoto, Y.; Ogawa, A.; Nakano, F.; Tomohiro, A.; Nakayama, K.; Taniguchi, M.;
et al. The Innate Immune Receptors TLR2/4 Mediate Repeated Social Defeat Stress-Induced Social Avoidance through Prefrontal
Microglial Activation. Neuron 2018, 99, 464–479.e7. [CrossRef]
Akiyama, S.; Nagai, H.; Oike, S.; Horikawa, I.; Shinohara, M.; Lu, Y.; Futamura, T.; Shinohara, R.; Kitaoka, S.; Furuyashiki, T.
Chronic social defeat stress increases the amounts of 12-lipoxygenase lipid metabolites in the nucleus accumbens of stress-resilient
mice. Sci. Rep. 2022, 12, 11385. [CrossRef]
Zhang, J.; Takahashi, H.K.; Liu, K.; Wake, H.; Liu, R.; Maruo, T.; Date, I.; Yoshino, T.; Ohtsuka, A.; Mori, S.; et al. Anti-high
mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats. Stroke 2011,
42, 1420–1428. [CrossRef]
Cells 2023, 12, 1789
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
13 of 13
Segi-Nishida, E.; Warner-Schmidt, J.L.; Duman, R.S. Electroconvulsive seizure and VEGF increase the proliferation of neural
stem-like cells in rat hippocampus. Proc. Natl. Acad. Sci. USA 2008, 105, 11352–11357. [CrossRef]
Paxinos, G.; Franklin, K.B. The Mouse Brain in Stereotaxic Coordinates: Section Edition, 2nd ed.; Academic Press: Cambridge, MA,
USA, 2003.
Yang, H.; Datta-Chaudhuri, T.; George, S.J.; Haider, B.; Wong, J.; Hepler, T.D.; Andersson, U.; Brines, M.; Tracey, K.J.; Chavan, S.S.
High-frequency electrical stimulation attenuates neuronal release of inflammatory mediators and ameliorates neuropathic pain.
Bioelectron. Med. 2022, 8, 16. [CrossRef] [PubMed]
Tian, J.; Avalos, A.M.; Mao, S.Y.; Chen, B.; Senthil, K.; Wu, H.; Parroche, P.; Drabic, S.; Golenbock, D.; Sirois, C.; et al. Toll-like
receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol. 2007,
8, 487–496. [CrossRef]
Frank, M.G.; Weber, M.D.; Watkins, L.R.; Maier, S.F. Stress sounds the alarmin: The role of the danger-associated molecular
pattern HMGB1 in stress-induced neuroinflammatory priming. Brain Behav. Immun. 2015, 48, 1–7. [CrossRef] [PubMed]
Schiraldi, M.; Raucci, A.; Muñoz, L.M.; Livoti, E.; Celona, B.; Venereau, E.; Apuzzo, T.; De Marchis, F.; Pedotti, M.; Bachi, A.; et al.
HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via
CXCR4. J. Exp. Med. 2012, 209, 551–563. [CrossRef] [PubMed]
Yang, H.; Hreggvidsdottir, H.S.; Palmblad, K.; Wang, H.; Ochani, M.; Li, J.; Lu, B.; Chavan, S.; Rosas-Ballina, M.; Al-Abed, Y.; et al.
A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc. Natl.
Acad. Sci. USA 2010, 107, 11942–11947. [CrossRef]
Bouvier, E.; Brouillard, F.; Molet, J.; Claverie, D.; Cabungcal, J.H.; Cresto, N.; Doligez, N.; Rivat, C.; Do, K.Q.; Bernard, C.;
et al. Nrf2-dependent persistent oxidative stress results in stress-induced vulnerability to depression. Mol. Psychiatry 2017, 22,
1701–1713. [CrossRef]
Ibi, M.; Liu, J.; Arakawa, N.; Kitaoka, S.; Kawaji, A.; Matsuda, K.I.; Iwata, K.; Matsumoto, M.; Katsuyama, M.; Zhu, K.; et al.
Depressive-Like Behaviors Are Regulated by NOX1/NADPH Oxidase by Redox Modification of NMDA Receptor 1. J. Neurosci.
2017, 37, 4200–4212. [CrossRef]
Toyokuni, S.; Iwasa, Y.; Kondo, S.; Tanaka, T.; Ochi, H.; Hiai, H. Intranuclear distribution of 8-hydroxy-2’-deoxyguanosine. An
immunocytochemical study. J. Histochem. Cytochem. 1999, 47, 833–836. [CrossRef]
Bonaldi, T.; Talamo, F.; Scaffidi, P.; Ferrera, D.; Porto, A.; Bachi, A.; Rubartelli, A.; Agresti, A.; Bianchi, M.E. Monocytic cells
hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J. 2003, 22, 5551–5560. [CrossRef]
Prantner, D.; Nallar, S.; Vogel, S.N. The role of RAGE in host pathology and crosstalk between RAGE and TLR4 in innate immune
signal transduction pathways. FASEB J. 2020, 34, 15659–15674. [CrossRef] [PubMed]
Broz, P.; Pelegrín, P.; Shao, F. The gasdermins, a protein family executing cell death and inflammation. Nat. Rev. Immunol. 2020,
20, 143–157. [CrossRef] [PubMed]
Li, S.; Sun, Y.; Song, M.; Song, Y.; Fang, Y.; Zhang, Q.; Li, X.; Song, N.; Ding, J.; Lu, M.; et al. NLRP3/caspase-1/GSDMD-mediated
pyroptosis exerts a crucial role in astrocyte pathological injury in mouse model of depression. JCI Insight 2021, 6, e146852.
[CrossRef] [PubMed]
Zhou, Z.; Liu, T.; Sun, X.; Mu, X.; Zhu, G.; Xiao, T.; Zhao, M.; Zhao, C. CXCR4 antagonist AMD3100 reverses the neurogenesis
promoted by enriched environment and suppresses long-term seizure activity in adult rats of temporal lobe epilepsy. Behav. Brain
Res. 2017, 322 Pt A, 83–91. [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual
author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to
people or property resulting from any ideas, methods, instructions or products referred to in the content.
...
論文の公開元へ
